MedMythBusters: Understanding GLP-1 and Obesity Medications
Describe the efficacy and safety of GLP-1 agonist or GIP/GLP-1 agonists to treat obesity along with Doctor Maria Isabel Esparza, Board certified in Internal Medicine, Endocrinology and Metabolism and Obesity.
Sign up to claim your credit at: MythObesity.dkbmed.com
GLP-1 agonists to lower blood sugar levels and promote weight loss have skyrocketed in popularity recently, but there are still many myths about them. In part 1, Dr. Esparza answers some of your burning questions about this class of obesity medications:
Does insurance cover the cost of these GLP-1 medications?
Do patients maintain their weight loss after stopping medication?
Do GLP-1 medications cause dangerous side effects?
Can conventional appetite suppressants achieve similar results as GLP-1s?
🙌🏼 Follow us on social media where where we’re always giving you the latest updates on our programs. ▪️Linkedin / dkbmed ▪️X / dkbmed ▪️Instagram / dkbmed_ ▪️Facebook / dkbmed ▪️TikTok: / dkbmed ▪️
#Obesity #obesityawareness #Clinicians #endocrinology #HealthCare #CME #FreeCME #MedicalEducation #CMEcredits #ContinuingEducation